| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2019 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 1,297 | $16.64 | $21,588.05 | -100% | |
| Mar 12, 2019 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 647 | $15.67 | $10,141.66 | -7.0% | |
| Mar 12, 2019 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 953 | $15.67 | $14,938.18 | -100% | |
| Mar 12, 2019 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 715 | $15.69 | $11,218.21 | -100% | |
| Mar 12, 2019 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,444 | $15.82 | $38,664.08 | -45.1% | |
| Mar 12, 2019 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 738 | $15.67 | $11,568.08 | -34.7% | |
| Mar 12, 2019 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 325 | $15.69 | $5,099.19 | -3.7% | |
| Mar 4, 2019 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 409 | $16.88 | $6,905.27 | -2.5% | |
| Mar 4, 2019 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 1,166 | $16.88 | $19,685.93 | -45.6% | |
| Mar 4, 2019 | McClellan Michael James | EVP, Chief Financial Officer | Sale+OE | 363 | $16.88 | $6,128.64 | -2.9% |